Evidence map›Paper›PMID 31660876›Full record

ArticleBMC infectious diseases2019

Chromosomal and plasmid-mediated fluoroquinolone resistance in human Salmonella enterica infection in Ghana.

Godfred Acheampong, Michael Owusu, Alex Owusu-Ofori, Isaac Osei, Nimako Sarpong, Augustina Sylverken, Hung-Jui Kung, Shu-Ting Cho, Chih-Horng Kuo, Se Eun Park and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Genomic characterization of respiratoryFrontiers in microbiology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Co-existence of extended-spectrum β-lactamases blaEuropean journal of medical research · 2023
    Article
  16. Article
  17. Article
  18. Epidemiology of Plasmids inAntibiotics (Basel, Switzerland) · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Godfred AcheampongKumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
Michael OwusuKumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
Alex Owusu-OforiDepartment of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Isaac OseiKumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
Nimako SarpongAgogo Presbyterian Hospital, Agogo, Ghana.
Augustina SylverkenKumasi Centre for Collaborative Research in Tropical Medicine, Kumasi, Ghana.
Hung-Jui KungInstitute of Plant and Microbial Biology, Academia Sinica, Taipei, Taiwan.
Shu-Ting ChoInstitute of Plant and Microbial Biology, Academia Sinica, Taipei, Taiwan.
Chih-Horng KuoInstitute of Plant and Microbial Biology, Academia Sinica, Taipei, Taiwan.
Se Eun ParkDepartment of Epidemiology, International Vaccine Institute, Seoul, South Korea.
Florian MarksDepartment of Epidemiology, International Vaccine Institute, Seoul, South Korea.
Yaw Adu-SarkodieDepartment of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.
Ellis Owusu-DaboDepartment of Global and International Health, School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana. owusudabo@yahoo.com.ORCID http://orcid.org/0000-0003-4232-4292
Kwame Nkrumah University of Science and Technology · GHInstitute of Plant and Microbial Biology, Academia Sinica · TWInternational Vaccine Institute · KRKumasi Centre for Collaborative Research in Tropical Medicine · GHKomfo Anokye Teaching Hospital · GHPresbyterian University, Ghana · GH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSalmonella infection poses significant public health threat globally, especially in resource-limited countries. Emergence and spread of antibiotic resistant strains to fluoroquinolones have led to treatment failures and increased mortality in Salmonella infection. However, there is dearth of information regarding mechanisms of resistance to fluoroquinolones in Ghana. This study therefore sought to identify chromosomal mutations and plasmid-mediated resistance as possible mechanisms of fluoroquinolone resistance from clinical isolates in Ghana.

methodsThis was a retrospective study of archived isolates biobanked at Kumasi Centre for Collaborative Research in Tropical Medicine, Ghana. Isolates were obtained from blood, stool and oropharynx samples at two hospitals, between May, 2016 and January, 2018. Salmonella identification was done using standard microbiological protocols and antibiotic susceptibility testing performed by Kirby-Bauer disc diffusion method. Isolates with intermediate susceptibility and/or resistance to nalidixic acid and/or ciprofloxacin were selected and examined for chromosomal mutations by Sanger sequencing and plasmid-mediated resistance by PCR.

resultsOf 133 biobanked isolates cultured, 68 (51.1%) and 16 (12%) were identified as Salmonella Typhi and non-typhoidal Salmonella (NTS), respectively. Sequence analysis of gyrA gene revealed the presence of 5 different nonsynonymous mutations, with the most frequent mutation (Ile203Ser) occurring in 12 out of 13 isolates tested. Gyrase B (gyrB) gene had 1 nonsynonymous mutation in 3 out of 13 isolates, substituting phenylalanine with leucine at codon 601 (Phe601Leu). No mutation was observed in parC and parE genes. Two NTS isolates were found to harbour qnrS plasmid-mediated resistant gene of molecular size 550 bp with high ciprofloxacin MIC of 0.5 μg/ml.

conclusionThis study reports for the first time in Ghana plasmid-mediated fluoroquinolone resistant gene qnrS in Salmonella clinical isolates. Nonsynonymous mutations of gyrA and gyrB genes likely to confer Salmonella reduced susceptibility to ciprofloxacin were also reported.

Indexed as

AdolescentAnti-Bacterial AgentsChild, PreschoolCiprofloxacinDisk Diffusion Antimicrobial TestsDNA GyraseDNA Topoisomerase IVDrug Resistance, BacterialFemaleFluoroquinolonesGenes, BacterialGhanaHumansMaleMutationPlasmidsAnti-Bacterial AgentsCiprofloxacinDNA GyraseDNA Topoisomerase IVFluoroquinolonesFluoroquinolone resistanceMutationsPlasmidsSalmonella enterica

Identifiers

PMID31660876
PMCPMC6819380
OpenAlexW2982187729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.